Anaemia is of prognostic significance in patients with oesophageal adenocarcinoma

Journal of the Royal College of Physicians of Edinburgh

Volumn 41, Issue 3, 2011, Pages 206-210

  Tanswell, I ^a   Steed, H ^a   Butterworth, J ^a   Townson, G ^a  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

Author keywords

Adenocarcinoma; Anaemia; Oesophageal cancer; Survival

Indexed keywords

HEMOGLOBIN;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGE; AGED; ANEMIA; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT PREFERENCE; PHYSICIAN ATTITUDE; SURVIVAL RATE; SURVIVAL TIME; WEIGHT REDUCTION; ADENOCARCINOMA; BLOOD; CANCER STAGING; DISEASE COURSE; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 84859391758     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/JRCPE.2011.304     Document Type: Article

References (18)

1. Ries LA, Eisner MP, Kosary CL et al, editors. SEER Cancer Statistics Review, 1975-2002. Bethesda: National Cancer Institute; 2005.
2. Schlansky B, Dimarino AJ, Loren D et al. A survey of oesophageal cancer: pathology, stage and clinical presentation. Aliment Pharmacol Ther 2006; 23:587-93. doi:10.1111/j.1365-2036.2006.02782.x
3. Office for National Statistics, 2009.
4. Clarke H, Pallister CJ. The impact of anaemia on outcome in cancer. Clin Lab Haematol 2005; 27:1-13. doi:10.1111/j.1365-2257.2004.00664.x
5. Knight K, Wade S, Balducci L. Prevalence and outcomes of anaemia in cancer: a systematic review of the literature. Am J Med 2004; 116:11s-26s. doi:10.1016/j.amjmed.2003.12.008
6. Dunst J, Pigorsch S, Hansgen G et al. Low haemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anaemia stimulate angiogenesis? Strahlenther Onkol 1999; 175:93-96. doi:10.1007/ BF02742340
7. In: Sobin LH, Wittkind CH editors. TNM Classification of Malignant Tumours. Anatomical localisation of the oesophagus (UICC). 5th edition. New York: Wiley-Liss; 1997. p. 54-58.
8. The American Society of Anaesthesiologists' physical status classification system. American Society of Anaesthesiologists [cited 2006]. Available at: http://www.asahq.org/clinical/physicalstatus.htm
9. Daly JM, Fry WA, Little AG et al. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Col Surg 2000; 190:562-72. doi:10.1016/S1072-7515(00)00238-6
10. Valencia Julve J, Alonso Orduña V, Escó Barón R et al. Influence of haemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy. Clin Transl Oncol 2006; 8:22-30. doi:10.1007/s12094-006-0091-z
11. Rades D, Schild SE, Bahrehmand R et al. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pre-treatment hemoglobin levels. Cancer 2005; 103:1740-46. doi:10.1002/cncr.20952
12. Rades D, Lang S, Schild SE et al. Prognostic value of haemoglobin levels during concurrent radio-chemotherapy in the treatment of oesophageal cancer. Clin Oncol 2006; 18:139-44. doi:10.1016/j. clon.2005.10.007
13. Zenda S, Hironaka S, Boku N et al. Impact of haemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer. Dis Esophagus 2008; 21:195-200. doi:10.1111/j.1442-2050.2007.00750.x
14. Zhao KL, Liu G, Jiang GL et al. Association of haemoglobin level with morbidity and mortality of patients with locally advanced oesophageal carcinoma undergoing radiotherapy - a secondary analysis of three consecutive clinical phase III trials. Clinical Oncology 2006; 18:621-27. doi:10.1016/j.clon.2006.04.015
15. Hofheinz RD, Raab B, Mai S et al. Impact of chemoradiotherapy-induced anaemia on survival in uniformly staged patients with locally advanced squamous cell carcinoma of the esophagus. Onkologie 2004; 27:4626-6. doi:10.1159/000080366
16. Voelter V, Schumacher C, Busch R et al. Incidence of anaemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer. Ann Thorac Surg 2004; 78:1037-41. doi:10.1016/j.athoracsur.2004.01.049
17. Kader AS, Lim JT, Berthelet E et al. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy. Am J Clin Oncol 2007; 30:492-97. doi:10.1097/01.coc.0000264177.66369.18
18. Abbrederis K, Bassermann F, Schuhmacher C et al. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma. Ann Thorac Surg 2006; 82:292-97. doi:10.1016/j.athoracsur.2006.01.097